💊 Obat A-Z 🧬 Target 🛠 Alat 📚 Panduan
Semua Obat Kelas Obat Area Terapeutik Efek Samping
Panduan Glosarium Linimasa
Perbandingan Perjalanan Obat Famili Obat
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

BRAF (BRAF Kinase)

BRAF

Serine/threonine kinase in the RAS/MAPK pathway, frequently mutated (V600E) in melanoma.

Fungsi

BRAF inhibitors (vemurafenib, dabrafenib) combined with MEK inhibitors are standard for BRAF-mutant melanoma.

Related Targets

CDK4/CDK6 (Cyclin-Dependent Kinase 4/6) CDK4/CDK6 BCR-ABL1 (BCR-ABL Fusion Protein) BCR-ABL1 EGFR (Epidermal Growth Factor Receptor) EGFR KDR (Vascular Endothelial Growth Factor Receptor 2) KDR MTOR (Mechanistic Target of Rapamycin) MTOR ALK (Anaplastic Lymphoma Kinase) ALK